Analysts See $0.56 EPS for Canon Inc. (CAJ); Bioscrip (BIOS) Sentiment Is 1.05

January 14, 2018 - By Clifton Ray

Analysts expect Canon Inc. (NYSE:CAJ) to report $0.56 EPS on January, 30.They anticipate $0.30 EPS change or 115.38% from last quarter’s $0.26 EPS. CAJ’s profit would be $608.36M giving it 17.37 P/E if the $0.56 EPS is correct. After having $0.52 EPS previously, Canon Inc.’s analysts see 7.69% EPS growth. The stock decreased 0.54% or $0.21 during the last trading session, reaching $38.9. About 277,991 shares traded or 70.58% up from the average. Canon Inc. (NYSE:CAJ) has risen 21.99% since January 14, 2017 and is uptrending. It has outperformed by 5.29% the S&P500.

BioScrip, Inc. provides home infusion services in the United States. The company has market cap of $382.55 million. The firm engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. It currently has negative earnings. It is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care.

Canon Inc. manufactures and sells office multifunction devices , plain paper copying machines, laser and inkjet printers, cameras, and lithography equipment. The company has market cap of $42.26 billion. The firm operates in three divisions: Office Business Unit, Imaging System Business Unit, and Industry and Others Business Unit. It has a 20.3 P/E ratio. The Office Business Unit segment makes, markets, and services a range of office MFDs, printers, copying machines for personal and office use, production print products for print professionals, laser multifunction printers, digital production printing systems, continuous feed printers, wide-format printers, and document solutions, as well as provides software, services, and solutions.

Among 3 analysts covering Canon (NYSE:CAJ), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. Canon had 5 analyst reports since November 20, 2015 according to SRatingsIntel. The firm earned “Underweight” rating on Wednesday, October 26 by JP Morgan. Macquarie Research downgraded Canon Inc. (NYSE:CAJ) on Friday, November 20 to “Neutral” rating. The rating was upgraded by CLSA on Friday, November 25 to “Outperform”. The stock of Canon Inc. (NYSE:CAJ) has “Underperform” rating given on Friday, July 15 by CLSA. JP Morgan downgraded Canon Inc. (NYSE:CAJ) on Thursday, January 7 to “Neutral” rating.

The stock decreased 5.66% or $0.18 during the last trading session, reaching $3. About 4.32M shares traded or 304.75% up from the average. BioScrip, Inc. (BIOS) has declined 29.17% since January 14, 2017 and is downtrending. It has underperformed by 45.87% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News